1. Jing Luo, Zheng Dong, Hui Xie, Wei Zhang, Linjing An, Zhe Yu, Xiujuan Chang, Yan Chen , Wuwei Yang, Kaiwen Hu , Fuquan Liu , Yongping Yang*.Efficacy and safety of percutaneous cryoablation for elderly patients with small hepatocellular carcinoma: A prospective multicenter study.Liver Int .2022.42(4).918-929.SCI |
2. Zhong Wang, Yi-Fan Wu, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Yu Zhang, Fu-Quan Liu.Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.World J Gastroenterol .2021.27(5).416-427.SCI |
3. Jun Liu # , Yigang Pei # , Yu Zhang, Yifan Wu, Fuquan Liu, Shanzhi Gu*.Predicting the prognosis of hepatocellular carcinoma with the treatment of transcatheter arterial chemoembolization combined with microwave ablation using pretreatment MR imaging texture features.Abdom Radiol (NY).2021.46(8).3748-3757.SCI |
4. Lei Wang #, Rengui Wang #, Chunyan Zhang , Zhendong Yue , Hongwei Zhao, Zhenhua Fan, Yifan Wu, Yu Zhang, Fuquan Liu , Jian Dong*.Hepatic parenchyma and vascular blood flow changes after TIPS with spectral CT iodine density in HBV-related liver cirrhosi.Sci Rep.2021.11(1).10535.SCI |
5. Zhang Yu# ,Wang Z, Yue ZD, Zhao HW, Wang L, Fan ZH, Wu YF, He FL, Liu FQ*.Accurate ultrasonography-based portal pressure assessment in patients with hepatocellular carcinoma..World J Gastrointest Oncol .2020.12(8): .931-941 .SCI |
6. Quan Chen, Yu Zhang, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Quan Liu.High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.J Hepatobiliary Pancreat Sci .2020.27(8).522-530.SCI |
7. Fu-Liang He , Rui-Zhao Qi , Yue-Ning Zhang , Ke Zhang, Yu-Zheng Zhu-Ge , Min Wang, Yu Wang , Ji-Dong Jia , Fu-Quan Liu*.Transjugular intrahepatic portosystemic shunt and splenectomy are more effective than endoscopic therapy for recurrent variceal bleeding in patients with idiopathic noncirrhotic portal hypertension.World J Clin Cases.2020.8(10).1871-1877.SCI |
8. Ting-Ting Li, Yi-Fan Wu, Fu-Quan Liu, Fu-Liang He.Hepatic amyloidosis leading to hepatic venular occlusive disease and Budd-Chiari syndrome: A case report.World J Clin Cases.2019.7(20).3282-3288.SCI |
9. Jian Dong, Fuliang He, Lei Wang, Zhendong Yue, Tingguo Wen, Rengui Wang, Fuquan Liu.Iodine density Changes in Hepatic and Splenic Parenchyma in Liver Cirrhosis with Dual Energy CT (DECT): A Preliminary Study.Acad Radiol .2019.26(7).872-877.SCI |
10. Fu-Liang He, Chuan Li, Fu-Quan Liu, Xing-Shun Qi.Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study.World J Clin Cases .2019.7(2).130-136.SCI |
11. Yu Zhang#, Fu-Quan Liu*,.Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study.World Journal of Clinical Cases.2019.7(12).1410-1420.SCI |
12. Xiaolong Qi , Weimin An , Fuquan Liu, Ruizhao Qi, Lei Wang , Yanna Liu, Chuan Liu, Yi Xiang, Jialiang Hui , Zhao Liu, Xingshun Qi, Changchun Liu , Baogang Peng, Huiguo Ding , Yongping Yang, Xiaoshun He , Jinlin Hou , Jie Tian, Zhiwei Li. Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension..Radiology.2019.290(2).370-377.SCI |
13. Yue Zhang#, Yi-Fan Wu,Fu-Quan Liu*.Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus.World Journal of Gastrointestinal Oncology.2019.11(4):.310-321.SCI |
14. Hongwei Zhao, Zhendong Yue, Lei Wang, Zhenhua Fa, Fuliang He, Xiaoqun Dong, Fuquan Liu.Benefits of Early Treatment for Patients with Hepatic Myelopathy Secondary to TIPS: A Retrospective Study in Northern China.Sci Rep .2018.8(1).15184.SCI |
15. Hong-bin Li.Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy.Canadian Journal of Gastroenterology and Hepatology.2018.2018.1-9.SCI |
16. Tingxue Song , Martin Rössle , Fuliang He, Fuquan Liu, Xiaozhong Guo , Xingshun Qi.Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.Dig Liver Dis.2018.50(4).323-330.SCI |
17. Fuquan Liu , Zhenyuan Ning, Yanna Liu , Dengxiang Liu, Jie Tian , Hongwu Luo , Weimin An , Yifei Huang , Jialiang Zou, Chuan Liu, Changchun Liu , Lei Wang , Zaiyi Liu, Ruizhao Qi , Changzeng Zuo , Qingge Zhang , Jitao Wang , Dawei Zhao .Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study.EBioMedicine .2018.36(2018).151-158.SCI |
18. Yi-Fan Wu, Tao Wang, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Fu-Quan Liu. Stents combined with iodine-125 implantation to treat main portal vein tumor thrombus.World J Gastrointest Oncol.2018.10(12).496-504.SCI |
19. 赵洪伟(1)刘福全(*).Transjugular intrahepatic portosystemic shunt for chronic portal vein thrombosis and incidence of hepatic eeplopathy.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE.2017.10(2).3486-3493.SCI |
20. Bin Qiu(1)• Kai Li(1#) • Xiaoqun Dong(*) • Fu-Quan Liu(*).Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor.Cardiovasc Intervent Radiol.2017. 44(9).1372-1382.SCI |
21. 李红彬(1)刘福全(*).门静脉灌注80%乙醇建立猪肝硬化门静脉高压模型.中国介入影像与治疗学.2017.14(4).247-251.核心期刊 |
22. 吴一凡(1)刘福全(*).TGF-β-Smad信号通路和上皮细胞-间充质转化在支架后血管狭窄中的研究进展.中国介入影像与治疗学.2017.14(3).182-185.核心期刊 |
23. 赵洪伟(1)刘福全(*).Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome.. Medicine (Baltimore).2017.96(49).e9080.SCI |
24. 王磊(1)刘福全(*).Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein..scientific reports.2017.7(1).10868.SCI |
25. 赵洪伟(1)刘福全(*).Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death.. Journal of International Medical Research.2017.45(3).1148-1157.SCI |
26. Xiaolong Qi, Fuquan Liu , Zhiwei Li, Sizhe Chen , Yanna Liu , Yongping Yang, Jinlin Hou .Insufficient accuracy of computed tomography-based portal pressure assessment in hepatitis B virus-related cirrhosis: An analysis of data from CHESS-1601 trial. Journal of Hepatology.2017.5(17).32277-32278.SCI |
27. 王磊(1)董晓群(*)刘福全(*).Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial.SCIENTIFIC REPORTS.2016.6.21011.SCI |
28. Wang L#, Xiao Z#, Yue Z, Zhao H, Fan Z, Zhao M, He F, Dai S, Qiu B, Yao J, Lin Q, Dong X, Liu F*.Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial.scientific report.2016.6(15).21011-21019.SCI |
29. 何福亮(1)董晓群(*)刘福全(*).Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins.SCIENTIFIC REPORTS.2016.6.36.80.SCI |
30. 赵洪伟(1)刘福全(*).Evaluation of mid- and long-term efficacy ofshunt limiting for hepatic myelopathy aftertransjugular intrahepatic portosystemic shunt. Clinics and research in hepatology and gastroenterology.2016.40(4).440-446.SCI |
31. 赵孟菲(1)刘福全(*).Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis.SCIENTIFIC REPORTS.2016.6.33069.SCI |
32. 何福亮(1)刘福全(*).Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.BIOMED RESEARCH INTERNATIONAL.2016.2016(2016).1-8.SCI |
33. Zhao H, Liu F*, Yue Z, Wang L, Fan Z..Evaluation of mid- and long-term efficacy of shunt limiting for hepatic myelopathy after transjugular intrahepatic portosystemic shunt..Clinics and Research in Hepatology and Gastroenterology.2015.40(4).440-446.SCI |
34. 郐涛,刘福全*,岳振东,赵洪伟,王磊,范振华,赵孟菲,何福亮,于海洋.经颈静脉门体静脉分流术与曲张静脉栓塞术联合应用的临床研究.传染病信息.2015.28(5).293-296.核心期刊 |
35. Yao J, Zuo L, An G, Yue Z, Zhao H, Wang L, Liu F*.Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.Journal of Gastrointestinal Liver Disease.2015.24(3).301-307.SCI |
36. Wang L, He FL, Liu FQ*, Yue ZD, Zhao HW.Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol.World Journal of Gastroenterology.2015.21(32).9544-9553.SCI |
37. He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ*.Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.World Journal of Gastroenterology.2015.21(8).2413-2418.SCI |
38. Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ*.Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.World Journal of Gastroenterol.2015.21(43).12439-12447.SCI |
39. 王磊,刘福全*,岳振东,赵洪伟.TIPS术后支架再狭窄或闭塞的介入治疗.首都医科大学学报.2014.35(1).136-139.核心期刊 |
40. 赵洪伟,刘福全*,岳振东,王磊.门静脉不同部位分流治疗肝肺综合征术后近、中期血气变化.介入放射学杂志.2014.01(23).26-30.核心期刊 |
41. He FL, Wang L, Yue ZD, Zhao HW, Liu FQ*.Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. World J Gastroenterol..World Journal of Gastroenterology.2014.20(33).11835-11839.SCI |
42. 赵洪伟,刘福全*,岳振东,王磊,范振华,董成宾.应用覆膜支架TIPS治疗不同类型慢性门静脉血栓术后肝性脑病发生探讨.介入放射学杂志.2014.23(8).672-678.核心期刊 |
43. 赵洪伟,刘福全*,岳振东,王磊.经颈静脉途径介入干预经颈静脉肝内门体静脉分流术分流后肝性脊髓病的临床疗效.中华放射学杂志.2013.47(3).239-244.核心期刊 |
44. 刘福全,岳振东,王磊等.经颈静脉肝内门体静脉分流术技术与围手术期安全性分析—附1126例.中华消化杂志.2013.33(5).331-335.核心期刊 |
45. 王磊; 刘福全*; 岳振东; 赵洪伟.损伤性肾出血的动脉栓塞治疗.放射学实践.2013.28(3).352-355.核心期刊 |
46. Xishan Zhu, Wei Shi, Weiping TAI, Fuquan Liu*.The comparition of biological characteristics and multi-lineage differentiation of bone marrow and adipose derived Mesenchymal stem cells.Cell Tissue Research.2012.350(2).277-87.SCI |
47. 王磊,刘福全*,岳振东,赵洪伟.应用介入技术建立猪肝硬化门脉高压模型的实验研究.介入放射学杂志.2012.21(9).756-759.核心期刊 |
48. 刘福全,邵雪梅,尹金淑.临床型硕士研究生科研能力培养统一考核量化标准初探.临床和实验医学杂志.2012.11(8).631-634.核心期刊 |
49. 姚健楠,刘福全*,胡志强.颈动脉血管成形和支架植入术治疗颅外颈动脉狭窄.中国微侵袭神经外科杂志.2012.17(4).145-147.核心期刊 |
50. 姚健楠,刘福全*.颅外颈动脉狭窄支架成形术围手术期安全性分析.中国临床医学影像杂志.2012.23(4).267-269.核心期刊 |
51. 姚健楠,刘福全*,岳振东,等.射频消融治疗原发性肝癌围手术期安全性分析.中国肿瘤临床.2012.39(7).404-407.核心期刊 |
52. 王磊,刘福全*,岳振东,赵洪伟.肝移植术后肝动脉狭窄介入治疗的近中期疗效评价.放射学实践.2012.(10).1120-1123. |
53. 刘福全*,岳振东,赵洪伟,王磊,李志伟,余灵祥,李捍卫,范振华,赵孟菲,姚健楠,左力.经颈静脉肝内门-体分流术后再次介入治疗肝硬化门静脉高压长期疗效及再次手术原因分析.中华放射学杂志.2012.46(9).830-835.核心期刊 |
54. 王磊,刘福全*,岳振东,赵洪伟.肝移植术后肝动脉狭窄介入治疗的近中期疗效评价.放射学实践.2012.27(10).1120-1123.核心期刊 |
55. 赵洪伟,刘福全*,岳振东,王磊.介入治疗8例肝豆状核变性并发严重门静脉高压的疗效.介入放射学杂志.2011.20(3).224-227.核心期刊 |
56. 岳振东,刘福全*,周蕾,赵宏伟,王磊.肝功能评价对肝硬化患者TIPSS的指导意义.山东医药.2010.50(20).34. |
57. 周蕾,刘福全*,岳振东,赵宏伟,张红梅,姜妮,赵艳杰,曹艺.TIPSS对原发性肝癌并门静脉高压症患者的治疗效果 .解放军医学杂志.2009.(07).924. |